Gary E. Frashier, 57 years old, was named to the new position of vice chairman of this biopharmaceutical company.
Mr. Frashier, formerly president, continues as chief executive officer.
Steven M. Peltzman, 47, chief operating officer, succeeds Mr. Frashier as president.
